The question that needs to be resolved is what exactly is happening in terms of product filing and why is Ranbaxy saying that the product filings have not been impacted, says Vikas Dandekar, India Bureau Chief, PharmAsiaNews.Com.
first published: Sep 16, 2013 11:16 am
A collection of the most-viewed Moneycontrol videos.
Iran–US Conflict: Will India’s Fiscal Deficit, Rupee & Markets Take a Hit? | Centre Point
Oil Shock: India’s Oil Security at Stake | Is an LNG Shock Coming for India? | Commodities with MC
Monday Mayhem in markets| Brent surges 18%, Global markets slide 2-8% | Nifty Set for Gap Down Open
PM Modi Speech: PM Modi Accuses TMC of Insulting President Murmu and Constitution
